查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1576547

非班太尔市场，按产品类型、应用、分销管道、最终用户、配方类型、治疗持续时间、动物类型 - 全球预测 2025-2030

Febantel Market by Product Type (Injection Solutions, Oral Suspensions, Powder), Application (Human Medicine, Veterinary Medicine), Distribution Channel, End-User, Formulation Type, Treatment Duration, Animal Type - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

按产品类型、应用、分销管道、最终用户、配方类型、治疗持续时间、动物类型分類的非班太尔市场，2023 年估值为41.2 亿美元，预计到2024 年将达到42.9 亿美元，复合年成长率预估为2030 年成长 4.96%，达到 57.8 亿美元。

按产品类型、应用、分销管道、最终用户、配方类型、治疗持续时间、动物类型分类的非班太尔是一种驱虫药，常用于兽医，主要用于对抗动物的寄生虫感染。对非班太尔的产品类型、应用、分销渠道、最终用户、製剂类型、治疗持续时间和动物类型的需求取决于其针对家畜、宠物和其他动物的胃肠蠕虫和其他寄生虫的用途。按产品类型、应用、分销管道、最终用户、剂型类型、治疗持续时间和动物类型划分，Febantel 的应用主要涵盖口服製剂与其他抗寄生虫药物的联合使用，以提高对 Masu 抗药性菌株的疗效。其最终用途涵盖多个领域，包括畜牧业、伴同性动物护理和兽医医院，在这些领域，寄生虫控制对于健康管理通讯协定至关重要。

主要市场统计
基准年[2023] 41.2亿美元
预计年份 [2024] 42.9亿美元
预测年份 [2030] 57.8亿美元
复合年增长率（%） 4.96%

市场动态凸显，人们对动物健康和福利意识的不断提高正在推动强劲的需求，同时由于气候变迁和集中农业实践导致寄生虫感染疾病不断增加。扩大畜牧业、提高宠物拥有率以及投资动物保健发展将带来成长机会。此外，具有改进安全性的新型配方的开发提供了潜在的成长轨迹。然而，市场扩张受到抗药性寄生虫的出现、严格的监管条件以及替代抗寄生虫治疗的竞争等限制因素的挑战。

创新的关键领域包括研究新的製剂技术，以提高非班太尔的生物有效性或将其更有效地与其他药物结合以解决抗药性问题。永续生产流程的开发也有空间，以满足环境法规的要求，预测技术的进步也可以识别新出现的风险并加强处理通讯协定。

KEYWORD 市场是一个竞争激烈的市场，其特点是广泛的研究和监管挑战。公司需要注重策略联盟和合併，以扩大产品系列和市场占有率。利用资料主导的洞察和以客户为中心的方法对于适应不断变化的消费者期望和法规环境、促进成长和保护市场领导地位至关重要。

市场动态：快速发展的非班太尔市场，按产品类型、应用、分销管道、最终用户、配方类型、治疗持续时间和动物类型揭示关键市场洞察

按产品类型、应用、分销管道、最终用户、配方类型、治疗持续时间和动物类型分類的非班太尔市场正在因供需的动态相互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 动物寄生虫感染增加
    • 全球转向联合治疗，结合非班太尔的产品类型、应用、分销管道、最终用户、配方类型、治疗持续时间和动物类型，以解决多种寄生虫感染疾病
    • 严格的法律规范确保兽用杀寄生虫剂的安全性和有效性
  • 市场限制因素
    • 依产品类型、应用、通路、最终用户、製剂类型、治疗週期和动物类型分類的非班太尔製剂研发成本较高
  • 市场机会
    • 动物用药品公司之间的联盟将按产品类型、应用、分销管道、最终用户、配方类型、治疗持续时间和动物类型扩展Febantel的产品系列
    • 抗寄生虫治疗配方的创新
  • 市场挑战
    • 按产品类型、应用、分销管道、最终用户、配方类型、处理持续时间和动物类型分類的废弃物环境影响和处置问题

波特的五力：驾驭非班太尔市场的策略工具，按产品类型、应用、分销管道、最终用户、配方类型、治疗持续时间和动物类型

波特的五力框架是了解非班太尔市场、按产品类型、应用、分销管道、最终用户、配方类型、治疗持续时间和动物类型分類的竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解产品类型、应用、分销管道、最终用户、配方类型、治疗持续时间和动物类型对非班太尔市场的外部影响

外部宏观环境因素在塑造非班太尔市场、产品类型、应用、分销管道、最终用户、製剂类型、治疗持续时间和动物类型的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析，以了解非班太尔市场、产品类型、应用、分销管道、最终用户、製剂类型、治疗期和动物类型的竞争格局

按产品类型、应用、分销管道、最终用户、配方类型、治疗持续时间和动物类型对非班太尔市场进行详细的市场占有率分析，可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵 Febantel 市场、供应商绩效评估（按产品类型、应用、分销管道、最终用户、配方类型、治疗持续时间、动物类型）

FPNV定位矩阵是按产品类型、应用、分销管道、最终用户、配方类型、治疗持续时间和动物类型评估Febantel市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，按产品类型、应用、分销管道、最终用户、配方类型、治疗持续时间和动物类型绘製非班太尔市场的成功之路。

按产品类型、应用、分销管道、最终用户、配方类型、治疗持续时间和动物类型对非班太尔市场进行策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 动物寄生虫感染盛行率增加
      • 全球向联合治疗的过渡，包括非班太尔产品类型、应用、分销管道、最终用户、製剂类型、治疗持续时间和动物类型，以管理多种寄生虫感染疾病
      • 严格的法规结构确保兽用杀寄生虫剂的安全性和有效性
    • 抑制因素
      • 按产品类型、应用、分销管道、最终用户、製剂类型、治疗持续时间和动物类型分類的与非班太尔製剂相关的研发活动成本高昂
    • 机会
      • 透过动物用药品公司之间的合作，按产品类型、应用、分销管道、最终用户、配方类型、治疗持续时间和动物类型扩展Febantel的产品系列
      • 抗寄生虫治疗配方的创新
    • 任务
      • 对环境影响和废弃物处理的担忧
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 非班太尔市场：依产品类型

  • 注射液
  • 口服混悬剂
  • 粉末
  • 药片

第七章 非班太尔市场：依应用分类

  • 人类医学
  • 兽医学
    • 家畜
      • 牛
      • 山羊
      • 猪
      • 羊
    • 宠物
      • 猫
      • 狗

第八章 非班太尔市场：依通路划分

  • 网路药房
  • 零售药房
  • 兽医诊所
  • 批发商

第 9 章 Febantel 市场：依最终用户分类

  • 农民
  • 宠物饲主
  • 製药公司
  • 兽医

第10章 非班太尔市场：按製剂类型

  • 复杂的药物处方
  • 单药製剂

第十一章 非班太尔市场：依治疗持续时间

  • 长期
  • 短期

第十二章 非班太尔市场：依动物类型

  • 伴同性动物
    • 鸟类
    • 猫
    • 狗
    • 小型哺乳动物
  • 家畜
    • 牛
    • 山羊
    • 马
    • 猪
    • 羊

第十三章 非班太尔美洲市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十四章亚太非班太尔市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十五章 欧洲、中东和非洲非班太尔市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十六章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • 1. Aurora Pharmaceutical
  • 2. Bayer AG
  • 3. Boehringer Ingelheim
  • 4. Ceva Sante Animale
  • 5. Chanelle Pharma
  • 6. Dechra Pharmaceuticals
  • 7. Elanco
  • 8. Glenmark Pharmaceuticals
  • 9. Huvepharma
  • 10. Krka, dd, Novo mesto
  • 11. Kyoritsu Seiyaku
  • 12. Meiji Seika Pharma
  • 13. Merck Animal Health
  • 14. Norbrook Laboratories
  • 15. Phibro Animal Health
  • 16. Sun Pharmaceutical Industries
  • 17. Vetcare
  • 18. Vetoquinol
  • 19. Virbac
  • 20. Zoetis
Product Code: MRR-535C6291879E

The Febantel Market was valued at USD 4.12 billion in 2023, expected to reach USD 4.29 billion in 2024, and is projected to grow at a CAGR of 4.96%, to USD 5.78 billion by 2030.

Febantel is an anthelmintic agent commonly used in veterinary medicine, predominantly to combat parasitic infections in animals. The necessity of Febantel arises from its efficacy in targeting gastrointestinal worms and other parasites across livestock, pets, and other animals, essential for maintaining animal health and productivity in agriculture. The application of Febantel primarily spans oral formulations in combination with other antiparasitics to enhance efficacy against resistant parasite strains. Its end-use scope extends to varied sectors, including livestock farming, companion animal care, and veterinary clinics, where parasite control is critical to health management protocols.

KEY MARKET STATISTICS
Base Year [2023] USD 4.12 billion
Estimated Year [2024] USD 4.29 billion
Forecast Year [2030] USD 5.78 billion
CAGR (%) 4.96%

Market dynamics highlight a robust demand driven by increasing awareness of animal health and welfare, juxtaposed with rising incidents of parasitic infections due to climate change and intensive farming practices. Growth opportunities emerge from expanding the livestock sector, rising pet ownership, and investments in animal healthcare advancements. Moreover, the development of novel formulations with improved safety profiles provides a potential growth trajectory. However, limitations persist due to the emergence of drug-resistant parasites, stringent regulatory landscapes, and competition from alternative antiparasitic treatments, which can pose challenges to market expansion.

Key areas for innovation involve research into new formulation techniques that increase the bioavailability of Febantel or combine it more effectively with other drugs to tackle resistance issues. There is also scope for developing sustainable production processes to align with environmental regulations, as well as advancements in prediction technologies to identify outbreak risks and enhance treatment protocols.

The nature of the Febantel market is competitive, characterized by extensive research and regulatory challenges. Companies are urged to focus on strategic collaborations and mergers to broaden their product portfolios and market presence. Leveraging data-driven insights and customer-centric approaches will be pivotal in adapting to evolving consumer expectations and regulatory environments, bolstering growth and safeguarding market leadership.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Febantel Market

The Febantel Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of parasitic infections in animals
    • Global shift towards combination therapies incorporating febantel to manage multiple parasitic infections
    • Stringent regulatory frameworks ensuring the safety and efficacy of veterinary parasiticides
  • Market Restraints
    • High cost of research and development activities associated with febantel formulation
  • Market Opportunities
    • Collaborations between veterinary pharmaceutical companies to expand febantel product portfolios
    • Innovations in antiparasitic treatment formulations
  • Market Challenges
    • Concerns over environmental impact and disposal of febantel waste products

Porter's Five Forces: A Strategic Tool for Navigating the Febantel Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Febantel Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Febantel Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Febantel Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Febantel Market

A detailed market share analysis in the Febantel Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Febantel Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Febantel Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Febantel Market

A strategic analysis of the Febantel Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Febantel Market, highlighting leading vendors and their innovative profiles. These include Aurora Pharmaceutical, Bayer AG, Boehringer Ingelheim, Ceva Sante Animale, Chanelle Pharma, Dechra Pharmaceuticals, Elanco, Glenmark Pharmaceuticals, Huvepharma, Krka, d. d., Novo mesto, Kyoritsu Seiyaku, Meiji Seika Pharma, Merck Animal Health, Norbrook Laboratories, Phibro Animal Health, Sun Pharmaceutical Industries, Vetcare, Vetoquinol, Virbac, and Zoetis.

Market Segmentation & Coverage

This research report categorizes the Febantel Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Injection Solutions, Oral Suspensions, Powder, and Tablets.
  • Based on Application, market is studied across Human Medicine and Veterinary Medicine. The Veterinary Medicine is further studied across Livestock and Pets. The Livestock is further studied across Cattle, Goats, Pigs, and Sheep. The Pets is further studied across Cats and Dogs.
  • Based on Distribution Channel, market is studied across Online Pharmacies, Retail Pharmacies, Veterinary Clinics, and Wholesale Distributors.
  • Based on End-User, market is studied across Farmers, Pet Owners, Pharmaceutical Companies, and Veterinarians.
  • Based on Formulation Type, market is studied across Combination-Drug Formulations and Single-Drug Formulations.
  • Based on Treatment Duration, market is studied across Long-Term and Short-Term.
  • Based on Animal Type, market is studied across Companion Animals and Livestock Animals. The Companion Animals is further studied across Birds, Cats, Dogs, and Small Mammals. The Livestock Animals is further studied across Cattle, Goats, Horses, Pigs, and Sheep.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of parasitic infections in animals
      • 5.1.1.2. Global shift towards combination therapies incorporating febantel to manage multiple parasitic infections
      • 5.1.1.3. Stringent regulatory frameworks ensuring the safety and efficacy of veterinary parasiticides
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of research and development activities associated with febantel formulation
    • 5.1.3. Opportunities
      • 5.1.3.1. Collaborations between veterinary pharmaceutical companies to expand febantel product portfolios
      • 5.1.3.2. Innovations in antiparasitic treatment formulations
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns over environmental impact and disposal of febantel waste products
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Febantel Market, by Product Type

  • 6.1. Introduction
  • 6.2. Injection Solutions
  • 6.3. Oral Suspensions
  • 6.4. Powder
  • 6.5. Tablets

7. Febantel Market, by Application

  • 7.1. Introduction
  • 7.2. Human Medicine
  • 7.3. Veterinary Medicine
    • 7.3.1. Livestock
      • 7.3.1.1. Cattle
      • 7.3.1.2. Goats
      • 7.3.1.3. Pigs
      • 7.3.1.4. Sheep
    • 7.3.2. Pets
      • 7.3.2.1. Cats
      • 7.3.2.2. Dogs

8. Febantel Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Online Pharmacies
  • 8.3. Retail Pharmacies
  • 8.4. Veterinary Clinics
  • 8.5. Wholesale Distributors

9. Febantel Market, by End-User

  • 9.1. Introduction
  • 9.2. Farmers
  • 9.3. Pet Owners
  • 9.4. Pharmaceutical Companies
  • 9.5. Veterinarians

10. Febantel Market, by Formulation Type

  • 10.1. Introduction
  • 10.2. Combination-Drug Formulations
  • 10.3. Single-Drug Formulations

11. Febantel Market, by Treatment Duration

  • 11.1. Introduction
  • 11.2. Long-Term
  • 11.3. Short-Term

12. Febantel Market, by Animal Type

  • 12.1. Introduction
  • 12.2. Companion Animals
    • 12.2.1. Birds
    • 12.2.2. Cats
    • 12.2.3. Dogs
    • 12.2.4. Small Mammals
  • 12.3. Livestock Animals
    • 12.3.1. Cattle
    • 12.3.2. Goats
    • 12.3.3. Horses
    • 12.3.4. Pigs
    • 12.3.5. Sheep

13. Americas Febantel Market

  • 13.1. Introduction
  • 13.2. Argentina
  • 13.3. Brazil
  • 13.4. Canada
  • 13.5. Mexico
  • 13.6. United States

14. Asia-Pacific Febantel Market

  • 14.1. Introduction
  • 14.2. Australia
  • 14.3. China
  • 14.4. India
  • 14.5. Indonesia
  • 14.6. Japan
  • 14.7. Malaysia
  • 14.8. Philippines
  • 14.9. Singapore
  • 14.10. South Korea
  • 14.11. Taiwan
  • 14.12. Thailand
  • 14.13. Vietnam

15. Europe, Middle East & Africa Febantel Market

  • 15.1. Introduction
  • 15.2. Denmark
  • 15.3. Egypt
  • 15.4. Finland
  • 15.5. France
  • 15.6. Germany
  • 15.7. Israel
  • 15.8. Italy
  • 15.9. Netherlands
  • 15.10. Nigeria
  • 15.11. Norway
  • 15.12. Poland
  • 15.13. Qatar
  • 15.14. Russia
  • 15.15. Saudi Arabia
  • 15.16. South Africa
  • 15.17. Spain
  • 15.18. Sweden
  • 15.19. Switzerland
  • 15.20. Turkey
  • 15.21. United Arab Emirates
  • 15.22. United Kingdom

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2023
  • 16.2. FPNV Positioning Matrix, 2023
  • 16.3. Competitive Scenario Analysis
  • 16.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aurora Pharmaceutical
  • 2. Bayer AG
  • 3. Boehringer Ingelheim
  • 4. Ceva Sante Animale
  • 5. Chanelle Pharma
  • 6. Dechra Pharmaceuticals
  • 7. Elanco
  • 8. Glenmark Pharmaceuticals
  • 9. Huvepharma
  • 10. Krka, d. d., Novo mesto
  • 11. Kyoritsu Seiyaku
  • 12. Meiji Seika Pharma
  • 13. Merck Animal Health
  • 14. Norbrook Laboratories
  • 15. Phibro Animal Health
  • 16. Sun Pharmaceutical Industries
  • 17. Vetcare
  • 18. Vetoquinol
  • 19. Virbac
  • 20. Zoetis

LIST OF FIGURES

  • FIGURE 1. FEBANTEL MARKET RESEARCH PROCESS
  • FIGURE 2. FEBANTEL MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL FEBANTEL MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL FEBANTEL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL FEBANTEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL FEBANTEL MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL FEBANTEL MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL FEBANTEL MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL FEBANTEL MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL FEBANTEL MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL FEBANTEL MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL FEBANTEL MARKET SIZE, BY TREATMENT DURATION, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL FEBANTEL MARKET SIZE, BY TREATMENT DURATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. GLOBAL FEBANTEL MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
  • FIGURE 19. GLOBAL FEBANTEL MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. AMERICAS FEBANTEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. AMERICAS FEBANTEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. UNITED STATES FEBANTEL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 23. UNITED STATES FEBANTEL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC FEBANTEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. ASIA-PACIFIC FEBANTEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA FEBANTEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 27. EUROPE, MIDDLE EAST & AFRICA FEBANTEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 28. FEBANTEL MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 29. FEBANTEL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. FEBANTEL MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL FEBANTEL MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL FEBANTEL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL FEBANTEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. FEBANTEL MARKET DYNAMICS
  • TABLE 7. GLOBAL FEBANTEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL FEBANTEL MARKET SIZE, BY INJECTION SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL FEBANTEL MARKET SIZE, BY ORAL SUSPENSIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL FEBANTEL MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL FEBANTEL MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL FEBANTEL MARKET SIZE, BY HUMAN MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL FEBANTEL MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL FEBANTEL MARKET SIZE, BY CATTLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL FEBANTEL MARKET SIZE, BY GOATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL FEBANTEL MARKET SIZE, BY PIGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL FEBANTEL MARKET SIZE, BY SHEEP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL FEBANTEL MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL FEBANTEL MARKET SIZE, BY PETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL FEBANTEL MARKET SIZE, BY CATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL FEBANTEL MARKET SIZE, BY DOGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL FEBANTEL MARKET SIZE, BY PETS, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL FEBANTEL MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL FEBANTEL MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL FEBANTEL MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL FEBANTEL MARKET SIZE, BY WHOLESALE DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL FEBANTEL MARKET SIZE, BY FARMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL FEBANTEL MARKET SIZE, BY PET OWNERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL FEBANTEL MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL FEBANTEL MARKET SIZE, BY VETERINARIANS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL FEBANTEL MARKET SIZE, BY COMBINATION-DRUG FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL FEBANTEL MARKET SIZE, BY SINGLE-DRUG FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL FEBANTEL MARKET SIZE, BY TREATMENT DURATION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL FEBANTEL MARKET SIZE, BY LONG-TERM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL FEBANTEL MARKET SIZE, BY SHORT-TERM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL FEBANTEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL FEBANTEL MARKET SIZE, BY BIRDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL FEBANTEL MARKET SIZE, BY CATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL FEBANTEL MARKET SIZE, BY DOGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL FEBANTEL MARKET SIZE, BY SMALL MAMMALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL FEBANTEL MARKET SIZE, BY LIVESTOCK ANIMALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL FEBANTEL MARKET SIZE, BY CATTLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL FEBANTEL MARKET SIZE, BY GOATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL FEBANTEL MARKET SIZE, BY HORSES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL FEBANTEL MARKET SIZE, BY PIGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL FEBANTEL MARKET SIZE, BY SHEEP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL FEBANTEL MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS FEBANTEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 59. AMERICAS FEBANTEL MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 60. AMERICAS FEBANTEL MARKET SIZE, BY PETS, 2018-2030 (USD MILLION)
  • TABLE 61. AMERICAS FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 62. AMERICAS FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. AMERICAS FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. AMERICAS FEBANTEL MARKET SIZE, BY TREATMENT DURATION, 2018-2030 (USD MILLION)
  • TABLE 65. AMERICAS FEBANTEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. AMERICAS FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 67. AMERICAS FEBANTEL MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 68. AMERICAS FEBANTEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 69. ARGENTINA FEBANTEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ARGENTINA FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. ARGENTINA FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 72. ARGENTINA FEBANTEL MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 73. ARGENTINA FEBANTEL MARKET SIZE, BY PETS, 2018-2030 (USD MILLION)
  • TABLE 74. ARGENTINA FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 75. ARGENTINA FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. ARGENTINA FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. ARGENTINA FEBANTEL MARKET SIZE, BY TREATMENT DURATION, 2018-2030 (USD MILLION)
  • TABLE 78. ARGENTINA FEBANTEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. ARGENTINA FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 80. ARGENTINA FEBANTEL MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 81. BRAZIL FEBANTEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. BRAZIL FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. BRAZIL FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 84. BRAZIL FEBANTEL MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 85. BRAZIL FEBANTEL MARKET SIZE, BY PETS, 2018-2030 (USD MILLION)
  • TABLE 86. BRAZIL FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 87. BRAZIL FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. BRAZIL FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. BRAZIL FEBANTEL MARKET SIZE, BY TREATMENT DURATION, 2018-2030 (USD MILLION)
  • TABLE 90. BRAZIL FEBANTEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. BRAZIL FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 92. BRAZIL FEBANTEL MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 93. CANADA FEBANTEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. CANADA FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. CANADA FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 96. CANADA FEBANTEL MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 97. CANADA FEBANTEL MARKET SIZE, BY PETS, 2018-2030 (USD MILLION)
  • TABLE 98. CANADA FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 99. CANADA FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. CANADA FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. CANADA FEBANTEL MARKET SIZE, BY TREATMENT DURATION, 2018-2030 (USD MILLION)
  • TABLE 102. CANADA FEBANTEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. CANADA FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 104. CANADA FEBANTEL MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 105. MEXICO FEBANTEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. MEXICO FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. MEXICO FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 108. MEXICO FEBANTEL MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 109. MEXICO FEBANTEL MARKET SIZE, BY PETS, 2018-2030 (USD MILLION)
  • TABLE 110. MEXICO FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 111. MEXICO FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. MEXICO FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. MEXICO FEBANTEL MARKET SIZE, BY TREATMENT DURATION, 2018-2030 (USD MILLION)
  • TABLE 114. MEXICO FEBANTEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. MEXICO FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 116. MEXICO FEBANTEL MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 117. UNITED STATES FEBANTEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. UNITED STATES FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. UNITED STATES FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 120. UNITED STATES FEBANTEL MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 121. UNITED STATES FEBANTEL MARKET SIZE, BY PETS, 2018-2030 (USD MILLION)
  • TABLE 122. UNITED STATES FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 123. UNITED STATES FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. UNITED STATES FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. UNITED STATES FEBANTEL MARKET SIZE, BY TREATMENT DURATION, 2018-2030 (USD MILLION)
  • TABLE 126. UNITED STATES FEBANTEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. UNITED STATES FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 128. UNITED STATES FEBANTEL MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 129. UNITED STATES FEBANTEL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC FEBANTEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC FEBANTEL MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC FEBANTEL MARKET SIZE, BY PETS, 2018-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC FEBANTEL MARKET SIZE, BY TREATMENT DURATION, 2018-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC FEBANTEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC FEBANTEL MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC FEBANTEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 143. AUSTRALIA FEBANTEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. AUSTRALIA FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. AUSTRALIA FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 146. AUSTRALIA FEBANTEL MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 147. AUSTRALIA FEBANTEL MARKET SIZE, BY PETS, 2018-2030 (USD MILLION)
  • TABLE 148. AUSTRALIA FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 149. AUSTRALIA FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. AUSTRALIA FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. AUSTRALIA FEBANTEL MARKET SIZE, BY TREATMENT DURATION, 2018-2030 (USD MILLION)
  • TABLE 152. AUSTRALIA FEBANTEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. AUSTRALIA FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 154. AUSTRALIA FEBANTEL MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 155. CHINA FEBANTEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. CHINA FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. CHINA FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 158. CHINA FEBANTEL MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 159. CHINA FEBANTEL MARKET SIZE, BY PETS, 2018-2030 (USD MILLION)
  • TABLE 160. CHINA FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 161. CHINA FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. CHINA FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. CHINA FEBANTEL MARKET SIZE, BY TREATMENT DURATION, 2018-2030 (USD MILLION)
  • TABLE 164. CHINA FEBANTEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. CHINA FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 166. CHINA FEBANTEL MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 167. INDIA FEBANTEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. INDIA FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. INDIA FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 170. INDIA FEBANTEL MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 171. INDIA FEBANTEL MARKET SIZE, BY PETS, 2018-2030 (USD MILLION)
  • TABLE 172. INDIA FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 173. INDIA FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. INDIA FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. INDIA FEBANTEL MARKET SIZE, BY TREATMENT DURATION, 2018-2030 (USD MILLION)
  • TABLE 176. INDIA FEBANTEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. INDIA FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 178. INDIA FEBANTEL MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 179. INDONESIA FEBANTEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. INDONESIA FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. INDONESIA FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 182. INDONESIA FEBANTEL MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 183. INDONESIA FEBANTEL MARKET SIZE, BY PETS, 2018-2030 (USD MILLION)
  • TABLE 184. INDONESIA FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 185. INDONESIA FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. INDONESIA FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. INDONESIA FEBANTEL MARKET SIZE, BY TREATMENT DURATION, 2018-2030 (USD MILLION)
  • TABLE 188. INDONESIA FEBANTEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. INDONESIA FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 190. INDONESIA FEBANTEL MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 191. JAPAN FEBANTEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. JAPAN FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. JAPAN FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 194. JAPAN FEBANTEL MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 195. JAPAN FEBANTEL MARKET SIZE, BY PETS, 2018-2030 (USD MILLION)
  • TABLE 196. JAPAN FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 197. JAPAN FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 198. JAPAN FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. JAPAN FEBANTEL MARKET SIZE, BY TREATMENT DURATION, 2018-2030 (USD MILLION)
  • TABLE 200. JAPAN FEBANTEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. JAPAN FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 202. JAPAN FEBANTEL MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 203. MALAYSIA FEBANTEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. MALAYSIA FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. MALAYSIA FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 206. MALAYSIA FEBANTEL MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 207. MALAYSIA FEBANTEL MARKET SIZE, BY PETS, 2018-2030 (USD MILLION)
  • TABLE 208. MALAYSIA FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 209. MALAYSIA FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. MALAYSIA FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. MALAYSIA FEBANTEL MARKET SIZE, BY TREATMENT DURATION, 2018-2030 (USD MILLION)
  • TABLE 212. MALAYSIA FEBANTEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. MALAYSIA FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 214. MALAYSIA FEBANTEL MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 215. PHILIPPINES FEBANTEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. PHILIPPINES FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. PHILIPPINES FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 218. PHILIPPINES FEBANTEL MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 219. PHILIPPINES FEBANTEL MARKET SIZE, BY PETS, 2018-2030 (USD MILLION)
  • TABLE 220. PHILIPPINES FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 221. PHILIPPINES FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 222. PHILIPPINES FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. PHILIPPINES FEBANTEL MARKET SIZE, BY TREATMENT DURATION, 2018-2030 (USD MILLION)
  • TABLE 224. PHILIPPINES FEBANTEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. PHILIPPINES FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 226. PHILIPPINES FEBANTEL MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 227. SINGAPORE FEBANTEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. SINGAPORE FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. SINGAPORE FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 230. SINGAPORE FEBANTEL MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 231. SINGAPORE FEBANTEL MARKET SIZE, BY PETS, 2018-2030 (USD MILLION)
  • TABLE 232. SINGAPORE FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 233. SINGAPORE FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. SINGAPORE FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. SINGAPORE FEBANTEL MARKET SIZE, BY TREATMENT DURATION, 2018-2030 (USD MILLION)
  • TABLE 236. SINGAPORE FEBANTEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. SINGAPORE FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 238. SINGAPORE FEBANTEL MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH KOREA FEBANTEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH KOREA FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH KOREA FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH KOREA FEBANTEL MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH KOREA FEBANTEL MARKET SIZE, BY PETS, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH KOREA FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH KOREA FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH KOREA FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH KOREA FEBANTEL MARKET SIZE, BY TREATMENT DURATION, 2018-2030 (USD MILLION)
  • TABLE 248. SOUTH KOREA FEBANTEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. SOUTH KOREA FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 250. SOUTH KOREA FEBANTEL MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 251. TAIWAN FEBANTEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 252. TAIWAN FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 253. TAIWAN FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 254. TAIWAN FEBANTEL MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 255. TAIWAN FEBANTEL MARKET SIZE, BY PETS, 2018-2030 (USD MILLION)
  • TABLE 256. TAIWAN FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 257. TAIWAN FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 258. TAIWAN FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 259. TAIWAN FEBANTEL MARKET SIZE, BY TREATMENT DURATION, 2018-2030 (USD MILLION)
  • TABLE 260. TAIWAN FEBANTEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. TAIWAN FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 262. TAIWAN FEBANTEL MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 263. THAILAND FEBANTEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 264. THAILAND FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 265. THAILAND FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 266. THAILAND FEBANTEL MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 267. THAILAND FEBANTEL MARKET SIZE, BY PETS, 2018-2030 (USD MILLION)
  • TABLE 268. THAILAND FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 269. THAILAND FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 270. THAILAND FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 271. THAILAND FEBANTEL MARKET SIZE, BY TREATMENT DURATION, 2018-2030 (USD MILLION)
  • TABLE 272. THAILAND FEBANTEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. THAILAND FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 274. THAILAND FEBANTEL MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 275. VIETNAM FEBANTEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. VIETNAM FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 277. VIETNAM FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 278. VIETNAM FEBANTEL MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 279. VIETNAM FEBANTEL MARKET SIZE, BY PETS, 2018-2030 (USD MILLION)
  • TABLE 280. VIETNAM FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 281. VIETNAM FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 282. VIETNAM FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 283. VIETNAM FEBANTEL MARKET SIZE, BY TREATMENT DURATION, 2018-2030 (USD MILLION)
  • TABLE 284. VIETNAM FEBANTEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 285. VIETNAM FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 286. VIETNAM FEBANTEL MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA FEBANTEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA FEBANTEL MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA FEBANTEL MARKET SIZE, BY PETS, 2018-2030 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA FEBANTEL MARKET SIZE, BY TREATMENT DURATION, 2018-2030 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA FEBANTEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA FEBANTEL MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA FEBANTEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 300. DENMARK FEBANTEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 301. DENMARK FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 302. DENMARK FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 303. DENMARK FEBANTEL MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 304. DENMARK FEBANTEL MARKET SIZE, BY PETS, 2018-2030 (USD MILLION)
  • TABLE 305. DENMARK FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 306. DENMARK FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 307. DENMARK FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 308. DENMARK FEBANTEL MARKET SIZE, BY TREATMENT DURATION, 2018-2030 (USD MILLION)
  • TABLE 309. DENMARK FEBANTEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 310. DENMARK FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 311. DENMARK FEBANTEL MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 312. EGYPT FEBANTEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 313. EGYPT FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 314. EGYPT FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 315. EGYPT FEBANTEL MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 316. EGYPT FEBANTEL MARKET SIZE, BY PETS, 2018-2030 (USD MILLION)
  • TABLE 317. EGYPT FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 318. EGYPT FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 319. EGYPT FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 320. EGYPT FEBANTEL MARKET SIZE, BY TREATMENT DURATION, 2018-2030 (USD MILLION)
  • TABLE 321. EGYPT FEBANTEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 322. EGYPT FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 323. EGYPT FEBANTEL MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 324. FINLAND FEBANTEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 325. FINLAND FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 326. FINLAND FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 327. FINLAND FEBANTEL MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 328. FINLAND FEBANTEL MARKET SIZE, BY PETS, 2018-2030 (USD MILLION)
  • TABLE 329. FINLAND FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 330. FINLAND FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 331. FINLAND FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 332. FINLAND FEBANTEL MARKET SIZE, BY TREATMENT DURATION, 2018-2030 (USD MILLION)
  • TABLE 333. FINLAND FEBANTEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 334. FINLAND FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 335. FINLAND FEBANTEL MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 336. FRANCE FEBANTEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 337. FRANCE FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 338. FRANCE FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 339. FRANCE FEBANTEL MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 340. FRANCE FEBANTEL MARKET SIZE, BY PETS, 2018-2030 (USD MILLION)
  • TABLE 341. FRANCE FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 342. FRANCE FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 343. FRANCE FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 344. FRANCE FEBANTEL MARKET SIZE, BY TREATMENT DURATION, 2018-2030 (USD MILLION)
  • TABLE 345. FRANCE FEBANTEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 346. FRANCE FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 347. FRANCE FEBANTEL MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 348. GERMANY FEBANTEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 349. GERMANY FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 350. GERMANY FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 351. GERMANY FEBANTEL MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 352. GERMANY FEBANTEL MARKET SIZE, BY PETS, 2018-2030 (USD MILLION)
  • TABLE 353. GERMANY FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 354. GERMANY FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 355. GERMANY FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 356. GERMANY FEBANTEL MARKET SIZE, BY TREATMENT DURATION, 2018-2030 (USD MILLION)
  • TABLE 357. GERMANY FEBANTEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 358. GERMANY FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 359. GERMANY FEBANTEL MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 360. ISRAEL FEBANTEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 361. ISRAEL FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 362. ISRAEL FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 363. ISRAEL FEBANTEL MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 364. ISRAEL FEBANTEL MARKET SIZE, BY PETS, 2018-2030 (USD MILLION)
  • TABLE 365. ISRAEL FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 366. ISRAEL FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 367. ISRAEL FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 368. ISRAEL FEBANTEL MARKET SIZE, BY TREATMENT DURATION, 2018-2030 (USD MILLION)
  • TABLE 369. ISRAEL FEBANTEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 370. ISRAEL FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 371. ISRAEL FEBANTEL MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 372. ITALY FEBANTEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 373. ITALY FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 374. ITALY FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 375. ITALY FEBANTEL MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 376. ITALY FEBANTEL MARKET SIZE, BY PETS, 2018-2030 (USD MILLION)
  • TABLE 377. ITALY FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 378. ITALY FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 379. ITALY FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 380. ITALY FEBANTEL MARKET SIZE, BY TREATMENT DURATION, 2018-2030 (USD MILLION)
  • TABLE 381. ITALY FEBANTEL MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 382. ITALY FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 383. ITALY FEBANTEL MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 384. NETHERLANDS FEBANTEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 385. NETHERLANDS FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 386. NETHERLANDS FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 387. NETHERLANDS FEBANTEL MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLI